Mepha Pharma AG - Lecapon-Mepha 150 mg / 37.5 mg / 200 mg, Lactab | | 65283 | | 05 | | Lecapon-Mepha 150 mg / 37.5 mg / 200 mg | | Lactab | | N04BA03 | | Levodopa, Decarboxylase Inhibitor and Comt Inhibitor | | 25.03.2015 | | |
| Composition | levodopum 150.0 mg, carbidopum 37.5 mg, entacaponum 200.0 mg, cellulosum microcristallinum, lactosum 80.0 mg, hydroxypropylcellulosum substitutum humile, povidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: E 171, hypromellosum, glycerolum, polysorbatum 80, E 172 (rubrum), E 122 2.88 mg, magnesii stearas pro compresso obducto. | Packungsbestandteile | | Coated tablets | | | Active Agent | Dose |
---|
Carbidopa | 37.5 mg | Entacapone | 200 mg | Levodopa | 150 mg |
| BAG: Active Agent | Dose |
---|
Carbidopa | 37.5 mg | Entacapone | 200 mg | Levodopa | 150 mg |
| | Inactive agents | Dose | additional_information |
---|
| | | | | | | 2.88 mg | color. | | | Überzug | | | color. | Glycerol | | | | | | Hypromellosum | | | | 80 mg | | | | | | | | Polysorbatum 80 | | | Povidone | | | Silica Colloidalis Anhydrica | | |
| |
| |
|